Profile
Bradlee Heckmann is the founder of Asha Therapeutics LLC.
He held the title of Chief Scientific Officer at the company.
Bradlee Heckmann active positions
| Companies | Position | Start |
|---|---|---|
Asha Therapeutics LLC
 Asha Therapeutics LLC Pharmaceuticals: OtherHealth Technology Asha Therapeutics LLC is an American life sciences company that specializes in precision drug design using its Prism™ technology to create curative therapeutics for diseases with high unmet medical needs in neurology, oncology, and infectious disease. Asha Therapeutics is located in the US. The company's lead therapeutic programs, Asha-624 and Asha-091, are expected to enter clinical trials by mid-2024 and are disease-modifying therapeutics for indications in amyotrophic lateral sclerosis, Parkinson's disease, and ME/CFS and long COVID, respectively. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Asha Therapeutics LLC
Asha Therapeutics LLC Pharmaceuticals: OtherHealth Technology Asha Therapeutics LLC is an American life sciences company that specializes in precision drug design using its Prism™ technology to create curative therapeutics for diseases with high unmet medical needs in neurology, oncology, and infectious disease. Asha Therapeutics is located in the US. The company's lead therapeutic programs, Asha-624 and Asha-091, are expected to enter clinical trials by mid-2024 and are disease-modifying therapeutics for indications in amyotrophic lateral sclerosis, Parkinson's disease, and ME/CFS and long COVID, respectively. | Health Technology |
- Stock Market
- Insiders
- Bradlee Heckmann
